口腔疣状癌术后放射治疗研究
基于美国国家癌症数据库2006至2015年数据,回顾性分析356例接受根治性手术的原发性口腔疣状癌患者。10.7%的患者术后接受放疗。多因素分析显示,术后放疗与距离医院较近及III-IV期疾病相关。多因素Cox回归和倾向性评分分析均未发现术后放疗带来总生存获益。作者认为,切缘阴性的单纯手术可能是口腔疣状癌的最佳治疗。
要点
- 口腔疣状癌术后放疗与距离医院较近及III-IV期疾病相关。
- 多因素Cox回归显示术后放疗无生存获益(校正HR 1.50,95%CI 0.74-3.05,P=0.23)。
- 倾向性评分分析同样未显示术后放疗带来总生存获益(P=0.41)。
核心结论
- 多因素分析中与术后放疗使用相关的变量包括距离医院较近和III-IV期疾病。
- 多因素生存分析和倾向性评分分析均未发现术后放疗带来明确的生存获益。
- 作者认为,切缘阴性的单纯手术可能是口腔疣状癌患者的最佳治疗。
研究设计与样本
- 回顾性队列研究,数据来自美国国家癌症数据库(NCDB)2006年至2015年。
- 共纳入356例接受根治性手术切除的成人原发性口腔疣状癌患者。
主要发现
- 10.7%的患者接受根治性手术切除后行术后放疗。
- 与术后放疗相关的变量包括每10英里距离(校正比值比[aOR] 0.81,95%CI 0.70-0.95)和III-IV期疾病(aOR分别为12.13和23.92)。
- 多因素Cox回归生存分析显示,与单纯手术相比,术后放疗无生存获益证据(校正风险比1.50,95%CI 0.74-3.05,P=0.23)。
- 倾向性评分分析同样显示术后放疗无总生存获益(P=0.41)。
关键数值与推荐
- 术后放疗使用率为10.7%。
- 每10英里距离的aOR为0.81(95%CI 0.70-0.95)。
- III期和IV期疾病的aOR分别为12.13和23.92。
- 术后放疗对比单纯手术的校正HR为1.50(95%CI 0.74-3.05),P=0.23。
- 倾向性评分分析P=0.41。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: We investigate the clinicopathologic and treatment factors associated with the use of postoperative radiation therapy (PORT) and its effect on overall survival (OS) for patients with oral cavity verrucous carcinoma (VC). STUDY DESIGN: Retrospective cohort study. METHODS: A retrospective cohort study of the National Cancer Database (NCDB) from 2006 to 2015 was performed. Multivariable logistic regression was used to identify independent predictive factors associated with the use of PORT. Cox Regression survival and propensity score analyses were used to evaluate the effect of PORT on mortality. RESULTS: A total of 356 adult patients with primary oral cavity VC who underwent definitive surgical resection were identified. A total of 10.7% of patients underwent definitive surgical resection followed by PORT. Variables associated with PORT included distance to the hospital per 10 miles (adjusted odds ratio [aOR], 0.81 [95% confidence interval (CI), 0.70-0.95]) and stage III-IV disease (aOR, 12.13 and 23.92, respectively). Multivariable Cox regression survival analysis indicated no evidence of survival benefit in patients undergoing PORT compared to surgery alone (adjusted hazard ratio 1.50 [0.74-3.05], P = .23). Propensity score analysis also showed no OS benefit with the use of PORT (P = .41). CONCLUSIONS: Variables associated with the use of PORT on multivariable analysis included closer distance to hospital and stage III-IV disease. No clear survival benefit with PORT was identified on either multivariable survival analysis or propensity score analysis. These results suggest that surgery alone with negative margins may be the optimal treatment for patients with oral cavity VC. LEVEL OF EVIDENCE: 4 Laryngoscope, 132:1953-1961, 2022.
引用
- Naik AN, Silverman DA, Rygalski CJ, et al. Postoperative Radiation Therapy in Oral Cavity Verrucous Carcinoma. Laryngoscope. 2022. PMID: 34989407. doi:10.1002/lary.30009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。